{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:57:56Z","timestamp":1790974676746,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients with microvascular invasion (MVI)-positive hepatocellular carcinoma (HCC) have shown promising results with adjuvant hepatic arterial infusion chemotherapy (HAIC) with FOLFOX after curative resection. The authors aim to develop an imaging-derived biomarker to depict MVI-positive HCC patients more precisely and promote individualized treatment strategies of adjuvant HAIC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>\n                      Patients with MVI-positive HCC were identified from five academic centers and utilized for model development (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =470). Validation cohorts were pooled from a previously reported prospective clinical study conducted [control cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =145), adjuvant HAIC cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =143)] (NCT03192618). The primary endpoint was recurrence-free survival (RFS). Imaging features were thoroughly reviewed, and multivariable logistic regression analysis was employed for model development. Transcriptomic sequencing was conducted to identify the associated biological processes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Arterial phase peritumoral enhancement, boundary of the tumor enhancement, tumor necrosis stratification, and boundary of the necrotic area were selected and incorporated into the nomogram for RFS. The imaging-based model successfully stratified patients into two distinct prognostic subgroups in both the training, control, and adjuvant HAIC cohorts (median RFS, 6.00 vs. 66.00\u00a0months, 4.86 vs. 24.30\u00a0months, 11.46 vs. 39.40\u00a0months, all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01). Furthermore, no significant statistical difference was observed between patients at high risk of adjuvant HAIC and those in the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.61). The area under the receiver operating characteristic curve at 2 years was found to be 0.83, 0.84, and 0.73 for the training, control, and adjuvant HAIC cohorts, respectively. Transcriptomic sequencing analyses revealed associations between the radiological features and immune-regulating signal transduction pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The utilization of this imaging-based model could help to better characterize MVI-positive HCC patients and facilitate the precise subtyping of patients who genuinely benefit from adjuvant HAIC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000001903","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T09:02:13Z","timestamp":1721898133000},"page":"872-883","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Imaging-based surrogate classification for risk stratification of hepatocellular carcinoma with microvascular invasion to adjuvant hepatic arterial infusion chemotherapy: a multicenter retrospective study"],"prefix":"10.1097","volume":"111","author":[{"given":"Lidi","family":"Ma","sequence":"first","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Wen","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Liver Surgery, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Xing","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Anesthesiology, Sun Yat-Sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Li","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Liver Surgery, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Geng","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Liao","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Zhujiang Hospital, Southern Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Hepatobilliary Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hunan Cancer Hospital; Changsha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Zhuhai People \u2018s Hospital (Zhuhai hospital affiliated with Jinan University), Zhuhai, P.R China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyong","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First People\u2019s Hospital of Foshan, Foshan, Guangdong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongping","family":"Guo","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Liver Surgery, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Liver Surgery, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanmiao","family":"Xie","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghe","family":"Lu","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center"},{"name":"Department of Liver Surgery, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20260304","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260304","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"R3-20260304","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"R4-20260304","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4251\/wjgo.v14.i9.1604","article-title":"Advances in postoperative adjuvant therapy for primary liver cancer","volume":"14","author":"Zeng","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"R5-20260304","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11684-021-0848-3","article-title":"Adjuvant treatment strategy after curative resection for hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"R6-20260304","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.22.01142","article-title":"Postoperative adjuvant hepatic arterial infusion chemotherapy with FOLFOX in hepatocellular carcinoma with microvascular invasion: a multicenter, phase III, randomized study","volume":"41","author":"Li","year":"2023","journal-title":"J Clin Oncol"},{"key":"R7-20260304","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1245\/s10434-020-08601-8","article-title":"Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: a preliminary report of a phase III, randomized controlled clinical trial","volume":"27","author":"Li","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R8-20260304","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00268-013-2426-6","article-title":"Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma","volume":"38","author":"Portolani","year":"2014","journal-title":"World J Surg"},{"key":"R9-20260304","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jhep.2021.09.034","article-title":"Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies","volume":"76","author":"Beaufrere","year":"2022","journal-title":"J Hepatol"},{"key":"R10-20260304","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molmed.2022.11.002","article-title":"Imaging genomics: data fusion in uncovering disease heritability","volume":"29","author":"Hartmann","year":"2023","journal-title":"Trends Mol Med"},{"key":"R11-20260304","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1148\/radiol.2021202553","article-title":"The biological meaning of radiomic features","volume":"298","author":"Tomaszewski","year":"2021","journal-title":"Radiology"},{"key":"R12-20260304","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nbt1306","article-title":"Decoding global gene expression programs in liver cancer by noninvasive imaging","volume":"25","author":"Segal","year":"2007","journal-title":"Nat Biotechnol"},{"key":"R13-20260304","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2214\/AJR.05.0512","article-title":"Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging","volume":"188","author":"Monzawa","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"R14-20260304","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1007\/s00330-021-07910-0","article-title":"Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE","volume":"31","author":"Kong","year":"2021","journal-title":"Eur Radiol"},{"key":"R15-20260304","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R16-20260304","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/jhep.2000.9409","article-title":"Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor\u2014a prospective randomized study of hepatitis C virus-related liver cancer","volume":"32","author":"Ikeda","year":"2000","journal-title":"Hepatology"},{"key":"R17-20260304","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejca.2022.02.012","article-title":"Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: a randomised controlled trial","volume":"166","author":"Shi","year":"2022","journal-title":"Eur J Cancer"},{"key":"R18-20260304","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2468-1253(19)30422-4","article-title":"Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial","volume":"5","author":"Li","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R19-20260304","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"key":"R20-20260304","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.30633","article-title":"Adjuvant treatment of hepatocellular carcinoma: prospect of immunotherapy","volume":"70","author":"Brown","year":"2019","journal-title":"Hepatology"},{"key":"R21-20260304","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2217\/fon-2020-0162","article-title":"IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation","volume":"16","author":"Hack","year":"2020","journal-title":"Future Oncol"},{"key":"R22-20260304","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/SLA.0b013e31821ad884","article-title":"Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria","volume":"254","author":"Lim","year":"2011","journal-title":"Ann Surg"},{"key":"R23-20260304","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0000000000003268","article-title":"Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation","volume":"273","author":"Lee","year":"2021","journal-title":"Ann Surg"},{"key":"R24-20260304","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12885-017-3050-x","article-title":"Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B","volume":"17","author":"Huang","year":"2017","journal-title":"BMC cancer"},{"key":"R25-20260304","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41416-023-02317-8","article-title":"Radiogenomics: a key component of precision cancer medicine","volume":"129","author":"Liu","year":"2023","journal-title":"Br J Cancer"},{"key":"R26-20260304","doi-asserted-by":"crossref","first-page":"100806","DOI":"10.1016\/j.jhepr.2023.100806","article-title":"Predicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma","volume":"5","author":"Meng","year":"2023","journal-title":"JHEP Rep"},{"key":"R27-20260304","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiol.2021203614","article-title":"Preoperative CT for characterization of aggressive macrotrabecular-massive subtype and vessels that encapsulate tumor clusters pattern in hepatocellular carcinoma","volume":"300","author":"Feng","year":"2021","journal-title":"Radiology"},{"key":"R28-20260304","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/ijc.34247","article-title":"The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma","volume":"151","author":"Zhang","year":"2022","journal-title":"Int J Cancer"},{"key":"R29-20260304","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12072-020-10012-6","article-title":"Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression","volume":"14","author":"Rhee","year":"2020","journal-title":"Hepatol Int"},{"key":"R30-20260304","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bjc.6690158","article-title":"Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast","volume":"79","author":"Leek","year":"1999","journal-title":"Br J Cancer"},{"key":"R31-20260304","doi-asserted-by":"crossref","first-page":"eabg3750","DOI":"10.1126\/sciadv.abg3750","article-title":"Comprehensive analysis of spatial architecture in primary liver cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci Adv"},{"key":"R32-20260304","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1053\/j.gastro.2021.04.064","article-title":"TGF-\u03b2 signaling in liver, pancreas, and gastrointestinal diseases and cancer","volume":"161","author":"Gough","year":"2021","journal-title":"Gastroenterology"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:06:15Z","timestamp":1772625975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000001903","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"2024-03-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}